• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thorac Dis . Development and validation of a pneumonia severity prediction model using AI analysis of abdominal and paravertebral intramuscular f

tetano

Editor, Senior Moderator
J Thorac Dis


. 2025 Oct 31;17(10):7487-7497.
doi: 10.21037/jtd-2025-353. Epub 2025 Sep 25. Development and validation of a pneumonia severity prediction model using AI analysis of abdominal and paravertebral intramuscular fat on chest CT in COVID-19 patients

Bin Lin[SUP] #[/SUP][SUP] 1 [/SUP], Xiao Luo[SUP] #[/SUP][SUP] 1 [/SUP], Liangji Lu[SUP] 1 [/SUP], Kaipeng Jin[SUP] 2 [/SUP], Zhiyuan Gao[SUP] 2 [/SUP], Baoxin Qian[SUP] 3 [/SUP], Shuyue Wang[SUP] 1 [/SUP], Peiyu Huang[SUP] 1 [/SUP], Minming Zhang[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Pneumonia severity assessment is critical for clinical intervention, yet traditional methods often lack precision. This study addresses the clinical need for noninvasive, accurate tools by evaluating artificial intelligence (AI)-driven analysis of chest computed tomography (CT) scans to predict pneumonia severity and disease progression in coronavirus disease 2019 (COVID-19) patients, leveraging body composition metrics.
Methods: This retrospective study included 314 COVID-19 patients who underwent chest CT scans. Inclusion criteria were confirmed COVID-19 diagnosis and availability of CT imaging. Pneumonia severity, determined as the gold standard by expert radiologists assessing lesion percentage on CT, was categorized into Grade 1 (1-24%) and Grades 2-4 (≥25%). AI software measured subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), paravertebral muscle (PM) area, mean CT values of PM, and the proportion of paravertebral intramuscular fat (PIMF). The dataset was split into training (70%) and validation (30%) samples to develop and test the prediction model. Significant parameters (P<0.05) were analyzed using Spearman correlation, and binary logistic regression identified independent predictors.
Results: The cohort included 314 patients {median age, 77 years [interquartile range (IQR): 69-85.2 years], 199 men}. Significant differences in PIMF proportion were observed across severity groups (P<0.05). PM area and mean CT values negatively correlated with PIMF proportion (r=-0.452, -0.395, all P<0.05). Binary logistic regression identified PIMF proportion (coef. =20.512) and PM mean CT values (coef. =-0.059) as independent predictors. The AUC for PIMF proportion was 0.700 [95% confidence interval (CI): 0.623-0.777], with sensitivity of 65% and specificity of 68% in the validation set.
Conclusions: These findings support the use of AI-based CT analysis in clinical settings to enhance early risk stratification and guide targeted interventions for COVID-19 patients.

Keywords: Obesity; arcopenia; computed tomography (CT); pneumonia.

 
Back
Top